Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › HiberGene Receives CE Mark for Group B Strep Test

HiberGene Receives CE Mark for Group B Strep Test

Oct 18, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Irish molecular diagnostics firm HiberGene announced today that it has received CE marking for its HG Group B Streptococcus (GBS) test for the detection of strep infection in pregnant women using rectovaginal swabs.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

  2. HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

  3. CDC Develops Test for Simultaneous Detection of COVID-19, Flu

  4. Labs Launching Employer SARS-CoV-2 Testing Programs as Businesses Reopen

    Premium

  5. Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.